Drug Pipeline

Our drug discovery programs from target identification through preclinical development.

KCNQ2 Anticonvulsant Program

Epilepsy (KCNQ2 mutations)

Targeted therapy for KCNQ2-related epilepsy using structure-based drug design and AI-enhanced virtual screening.

GABA-A Receptor Allosteric Modulator

Anxiety disorders

Subtype-selective allosteric modulators of GABA-A receptors with improved safety profiles.

AI-Enhanced Virtual Screening Pipeline

Generalizable platform

A generalizable computational pipeline for rapid virtual screening against emerging drug targets.